Need help navigating aged care? Explore our support services
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Side effects warning about quit smoking drug Varenicline (Champix)

Posted
by DPS

The National Prescribing Service Limited (NPS), advises people taking the quit smoking drug, Varenicline (marketed in Australia as Champix), to speak to their GP or pharmacist, or contact Medicines Line if they are concerned about possible side effects.
 
In its December newsletter, the Adverse Drugs Reactions Advisory Committee (ADRAC), said it had received a number of adverse reaction reports for Varenicline, which included depression, aggression, agitation, abnormal dreams, insomnia, hallucination and anger, as well as reports of suicidal/self-injurious ideation or behaviour.
 
“As is often the case with any new medicine, it is only once it has been on the market for awhile and more people use it that unknown side effects come to light,” NPS CEO, Lynn Weekes said.

“Varenicline is still a useful medicine for those who have been unsuccessful with other smoking cessation products and methods.

“While these side effects are serious, and should be taken into consideration before starting this medicine, the number of reported adverse events indicates only a small percentage of patients have been affected.
 
“If you think you have experienced a side effect, speak to your GP or pharmacist, or call Medicines Line on 1300 888 763, which is an information service operated by a pharmacist, for people who have queries about their medicines.
 
“If you are caring for someone who is taking Varenicline, keep an eye on their behaviour, especially if they have a history of psychiatric illness.”
 
Prescribers are reminded to discuss possible side effects of Varenicline with patients, and exercise caution when prescribing it to patients with a history of seizure disorder.

A number of resources on Varenicline are available for consumers and healthcare professionals through the NPS website, including the consumer medicine information (CMI) sheet, peer reviews and journal articles.
 
“When starting any new medicine, people should read the Consumer Medicine Information (CMI) sheet which explains how the medicine works, what it is for, how best to take it, and any potential side effects,” Dr Weekes said.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo